Patents by Inventor Louis Pérusse

Louis Pérusse has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 9554754
    Abstract: A system, method and computer program for integrated, personalized disease management is provided. The method involves capturing individual attributes, analyzing the individual attributes to establish an individual classification for an individual, and based on the individual classification for the individual assigning automatically a program template for disease management of the individual. The system provides a coaching platform for managing interactions between a coach and a system client based on the program template.
    Type: Grant
    Filed: February 26, 2010
    Date of Patent: January 31, 2017
    Inventors: Jeffrey Ruby, Louis Pèrusse, Karyn Hood, Mary Bamford, Jean-Jacques Dugoua, Natasha Vani
  • Publication number: 20110172497
    Abstract: A system, method and computer program for integrated, personalized disease management is provided. The method involves capturing individual attributes, analyzing the individual attributes to establish an individual classification for an individual, and based on the individual classification for the individual assigning automatically a program template for disease management of the individual. The system provides a coaching platform for managing interactions between a coach and a system client based on the program template.
    Type: Application
    Filed: February 26, 2010
    Publication date: July 14, 2011
    Inventors: Jeffrey Ruby, Louis Pérusse, Karyn Hood, Mary Bamford, Jean-Jaques Dugoua, Natasha Vani
  • Publication number: 20100136561
    Abstract: This application relates to methods and tests that allow for the establishment of personalized weight-loss programs for a subject based upon the subject's metabolic genotype in key metabolic genes. Kits and methods are disclosed for determining a subject's metabolic genotype, which may be used to select an appropriate therapeutic/dietary regimen or lifestyle recommendation based upon the likelihood of a subject's responsiveness to certain diets and activity levels. Such a personalized weight-loss program will have obvious benefits (e.g., yield better results in terms of weight loss and weight maintenance) over traditional weight-loss programs that do not take into account genetic information.
    Type: Application
    Filed: November 18, 2009
    Publication date: June 3, 2010
    Applicant: INTERLEUKIN GENETICS, INC.
    Inventors: Colleen Draper, Leon Wilkins, Gary Breton, Louis Perusse
  • Publication number: 20100105038
    Abstract: This application relates to methods and tests that allow for the establishment of personalized weight-loss programs for a subject based upon the subject's metabolic genotype in key metabolic genes. Kits and methods are disclosed for determining a subject's metabolic genotype, which may be used to select an appropriate therapeutic/dietary regimen or lifestyle recommendation based upon the likelihood of a subject's responsiveness to certain diets and activity levels. Such a personalized weight-loss program will have obvious benefits (e.g., yield better results in terms of weight loss and weight maintenance) over traditional weight-loss programs that do not take into account genetic information.
    Type: Application
    Filed: May 15, 2009
    Publication date: April 29, 2010
    Applicant: Interleukin Genetics, Inc.
    Inventors: Colleen Draper, Leon Wilkins, Gary Breton, Louis Perusse
  • Publication number: 20080153084
    Abstract: The present invention relates to a method for identification of a nucleotide substitution in the gene encoding for the neuromedin- or quantifying its levels of mRNA, to allow the determination of the susceptibility or predisposition of a patient to obesity, or to disinhibition or susceptibility to hunger. Determination of the susceptibility or predisposition to obesity or to hunger disinhibition can alternatively be determined by the identification of an amino acid.
    Type: Application
    Filed: July 28, 2004
    Publication date: June 26, 2008
    Applicant: Universite Laval
    Inventors: Louis Perusse, Luigi Bouchard
  • Publication number: 20050191678
    Abstract: A method for assessing susceptibility of a subject to a genetically related disease or condition relative to a general population. The method includes the steps of: determining the presence or absence of a plurality of risk factors associated with the subject and having a correlation with the disease or condition; assigning a risk score, to each of the selected risk factors determined to be present, based upon a strength of correlation assigned to the factor with respect to the disease or condition; and combining the risk scores to calculate an overall susceptibility score, wherein the overall susceptibility score represents susceptibility of the subject to the disease or condition in relation to a base score representing the risk that a member of the general population will have the disease or condition without consideration of risk factors.
    Type: Application
    Filed: February 11, 2005
    Publication date: September 1, 2005
    Applicant: GeneOb USA Inc.
    Inventors: Gilles Lapointe, Louis Perusse